Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Harvard Apparatus Regenerative Technology, Inc.BSTG · Entity 7501 | Chief Scientific Officer | December 29, 2021 | January 04, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Harvard Apparatus Regenerative Technology, Inc.
Report date December 29, 2021 · Filed January 04, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.30 · Expires 2031-12-29 | Direct | 196,103 |
Reported balance
After 2021-12-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-12-29 · Grant · Acquired 196,103 · Balance 196,103 F1: Subject to continued employment or service through the applicable vesting dates, these shares vest in four equal amounts on each of the grant date and each anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Subject to continued employment or service through the applicable vesting dates, these shares vest in four equal amounts on each of the grant date and each anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 29, 2021 Filed Jan 4, 2022 00:02 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantStock Option (right to buy) · Derivative | 196,103 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001104659-22-000550 · tm221395-2_4seq1.xml · derivative · entry 1 Fodor William · CIK 0001735547 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,103 Underlying: Common Stock, par value $0.01 per share · 196,103 shares Expires 2031-12-29 F1 · derivative.exercise_date: Subject to continued employment or service through the applicable vesting dates, these shares vest in four equal amounts on each of the grant date and each anniversary of the grant date. Read SEC document |
| May 29, 2018 Filed Jun 1, 2018 00:22 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantStock Option (right to buy) · Derivative | 104,643 | $0.00 Strike: $2.72 | $0.00 |
DisclosureSEC source: 0001144204-18-032120 · tv495612_form4.xml · derivative · entry 2 Fodor William · CIK 0001735547 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,643 Underlying: Common Stock, par value $0.01 per share · 104,643 shares Expires 2028-05-29 F2 · derivative.exercise_date: Non-Qualified Stock Option that shares vest based on certain performance milestones. Read SEC document |
| May 29, 2018 Filed Jun 1, 2018 00:22 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantStock Option (right to buy) · Derivative | 104,643 | $0.00 Strike: $2.72 | $0.00 |
DisclosureSEC source: 0001144204-18-032120 · tv495612_form4.xml · derivative · entry 1 Fodor William · CIK 0001735547 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,643 Underlying: Common Stock, par value $0.01 per share · 104,643 shares Expires 2028-05-29 F1 · derivative.exercise_date: Incentive Stock Option shares that vest in four equal installments on December 31, 2018, 2019, 2020 and 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.